Savira pharmaceuticals is dedicated to the development of novel, innovative anti-influenza therapeutics following a rational.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Vienna
State: Wien
Zip:
Country: Austria
Savira pharmaceuticals GmbH was founded in July 2009 by the European Molecular Biology Laboratory (EMBL), onepharm Research and Development GmbH, private investors, and management. Led by CEO Oliver Szolar and CSO Helmut Buschmann, a seasoned management team combines scientific, technological, and business experience in the pharmaceutical industry. Savira follows the biotech business model, turning capital and public grants into the preclinical and clinical development of a portfolio of anti-influenza drug candidates. Savira thus strives to create a sustainable pipeline, generate value for shareholders, improve quality of life for people suffering from influenza, and add to the arsenal of antivirals thus improving influenza pandemic preparedness.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2009 | Seed Round | 1 | - |
i4g Investment i4g Investment |
7/2009 | Seed Round | 1 | - |
i4g Investment i4g Investment |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|